PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12074198

Quantifying gene expression.

Charles M Roth
View original source ↗Export metadata ↓

Abstract

Identifying those genes that are expressed and at what levels is an essential part of almost any biological inquiry at the cellular level. Techniques such as Northern blot have been in existence for decades to perform this task, but advances in molecular biology and bioinstrumentation have led to the development of a variety of new techniques with a range of sensitivities, throughputs and quantitative capabilities. This review focuses on the latter issue. For several commonly used gene expression techniques, the extent and range of quantitative applicability are reviewed, and approaches for maximizing the accuracy and precision of these measurements are discussed.

Explore related subjects

Gene ExpressionGene Expression ProfilingGenomeHumansOligonucleotide Array Sequence AnalysisPolymerase Chain ReactionRNASensitivity and SpecificityJournal ArticleResearch Support, Non-U.S. Gov'tReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Charles M Roth. 2002. Quantifying gene expression.. https://pubmed.ncbi.nlm.nih.gov/12074198/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Protocol to improve isoform-level quantification of low-abundance transcripts via STALARD pre-amplification.

STALARD (selective target amplification for low-abundance RNA detection) enables isoform-level quantification of low-abundance RNAs using conventional laboratory equipment. Here, we describe steps for RNA isolation, primer design, reverse transcription, selective target amplification, and downstream analysis. The protocol couples selective pre-amplification with a quantitative reverse-transcription PCR (RT-qPCR) readout and optional nanopore sequencing. Using 1 μg input RNA and 12 pre-amplification cycles, STALARD reduces Cq values by approximately 10-12 cycles, bringing the target into a reliably quantifiable range. For complete details on the use and execution of this protocol, please refer to Jeong et al.1.

Gene Expression↗
PubMed2003

Measures of genotype versus gene products: promise and pitfalls in cancer prevention.

We present a critical assessment of the promise and pitfalls of genotype versus gene function measures in cancer epidemiology studies. While both measures have pros and cons and are complementary, in terms of potential for contributing knowledge that directly leads to prevention, we argue that attention should be given to research relating functional parameters (single protein expression, functional or phenotypic assays or patterns of gene/protein expression) to disease risk. We present the theoretical and conceptual basis of why studies focusing on polymorphisms in the low-penetrance genes may be logically less fruitful for making inroads to cancer prevention than appropriately designed studies using validated functional parameters. We then substantiate these arguments with some concrete examples based on the current literature. We also discuss the limitations of including functional parameters in epidemiological studies and technical improvements required before such studies can truly fulfil their promise. Finally, we offer some specific recommendations for future research directions in this area.

Gene Expression↗
PubMed2003

Specificity of short interfering RNA determined through gene expression signatures.

Short interfering RNA (siRNA) is widely used for studying gene function and holds great promise as a tool for validating drug targets and treating disease. A critical assumption in these applications is that the effect of siRNA on cells is specific, i.e., limited to the specific knockdown of the target gene. In this article, we characterize the specificity of siRNA by applying gene expression profiling. Several siRNAs were designed against different regions of the same target gene for three different targets. Their effects on cells were compared by using DNA microarrays to generate gene expression signatures. When the siRNA design and transfection conditions were optimized, the signatures for different siRNAs against the same target were shown to correlate very closely, whereas the signatures for different genes revealed no correlation. These results indicate that siRNA is a highly specific tool for targeted gene knockdown, establishing siRNA-mediated gene silencing as a reliable approach for large-scale screening of gene function and drug target validation.

Gene Expression↗